4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole

The title compound, C18H13Br3N2S2, was obtained via the reaction of N-bromosuccinamide with 5,6-dimethyl-2-(thiophen-2-yl)-1-[(thiophen-2-yl)methyl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromothiophen-2-yl substituent with a refined major:minor occupancy ratio of 0.876...

Full description

Bibliographic Details
Main Authors: H. Cristina Geiger, James S. Donohoe, David K. Geiger
Format: Article
Language:English
Published: International Union of Crystallography 2014-04-01
Series:Acta Crystallographica Section E
Online Access:http://scripts.iucr.org/cgi-bin/paper?S160053681400628X